Controlling the dose of a liver transplant rejection drug reduces the risk of developing cancer
A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the deve...
A multi-centre study, in which the Clínic-IDIBAPS participated, identified, in nearly 2,500 transplant patients, the main risk factors for the deve...
EBRAINS is a new digital research infrastructure, created by the EU-funded Human Brain Project, which brings together a wide range of data and tool...
Founded in 1972, the Hospital Clínic de Barcelona Cardiology Service is celebrating its 50th anniversary this year. Dr. Ana Garcia, Head of the Car...
The activity is part of a new project of the institution to publicize the research done by IDIBAPS to patients and patient associations.
Intestinal microbiota performs essential functions in our body but can sometimes be damaged by taking antibiotics, or certain treatments such as ch...
The results of the study, carried out by researchers from Hospital Clínic-IDIBAPS and CIBERES, will make it possible to design new therapies for ch...
Regenerating and protecting pancreatic beta cells, which are responsible for producing and secreting insulin, are two of the areas of research bein...
Treatment with gene therapy, however, reverses the damage caused by deposits of α-synuclein in the neuron circuits and alleviates neuropsychiatric...
The Hospital Clínic de Barcelona, through the Urology Service, led by Dr. Antonio Alcaraz has started to perform surgeries to reverse male infertil...
The document establishes the basis for the exploitation and development of patented technology, owned by six research centers, including IDIBAPS.